Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

ConditionsLung Cancer Lung Adenocarcinoma Lung Squamous Cell Carcinoma Non Small Cell Lung Cancer Small-cell Lung Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences

About this trial

This study is a multi-center, observational, real-world study for patients with resected lung cancers in China. With the help of a properly designed data processing algorithm and extensively performed data quality assurance, this study aims to harness the potential of real-world big data to (1) describe characteristics and treatment patterns and their evolving trends; (2) discover features associated with overall survival; and (3) address recently-emerging clinical questions.

Eligibility criteria

Qualifiers

Age above 18.

Have received surgical resection for lung malignancies.

Disqualifiers

Participants whose data are of low quality, poor completeness or poor internal linkage.

Trial design

Treatments tested in this trial

Not listed

Trial groups

60,000 Participants

are grouped into 1 trial group

Locations

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College100021, BeijingBeijing Municipality, China

Sponsors and collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Lead sponsor

Source ClinicalTrials.gov